Heart Health | Genesis Healthcare System

Because of you, we are a Top 50 Heart Hospital for the 2nd year in a row

Read more about Because of you, we are a Top 50 Heart Hospital for the 2nd year in a row

In addition to rating hospitals, Fortune Magazine and PINC AI also rate the Top 50 Heart Hospitals because heart disease is the deadliest thing facing adults in the United States. According to the Centers for Disease Control and Prevention (CDC), someone has a heart attack every 40 seconds.

The seriousness of heart disease is also why, with your support, Genesis HealthCare System established the Heart & Vascular Institute. We adhere to the highest standards when recruiting physicians, surgeons and team members. We continually adopt proven new procedures and offer several minimally invasive options for common heart-related ailments.

Between the hundreds of team members who support our Heart & Vascular Institute and the thousands of community members who trust us with their health, we have the honor of being a Top 50 Heart Hospital for the second year in a row.

What does Top 50 Heart Hospital mean?

28% fewer acute myocardial infarction (AMI) deaths and 50% fewer coronary artery bypass grafting (CABG) deaths.
32% fewer percutaneous coronary interventions (PCI) and 38% fewer CABG patients with complications. Higher 30-day survival rates for acute myocardial infarction (AMI), heart failure (HF) and CABG patients (0.3 to 0.7% higher).
Higher 30-day survival rates for acute myocardial infarction (AMI), heart failure (HF) and CABG patients (0.3 to 0.7% higher).
Lower 30-day readmission rates for AMI, HF and CABG patients (0.4 to 0.8% points lower).
Shorter average lengths of stay between patient groups – 0.3 for AMI, 0.6 for HF, 0.3 for PCI and one full day for CABG.
$2,503 to $9,931 less in total costs per patient case.
Patients had a better experience at top performing hospitals compared to the remaining peer hospitals, with a top-box Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) score of 71% versus 67%.

Heart Health

Wed, 05/08/2024 - 15:06

Exclude From Search

Genesis is one of America’s top 50 heart hospitals

Read more about Genesis is one of America’s top 50 heart hospitals

Awarded by Fortune/PINC AI

For more than 70 years, heart disease has taken more American lives than any other illness or injury. That is why Genesis HealthCare System created the Genesis Heart & Vascular Institute. It is why we recruit the best heart doctors and invest in the most innovative technology to perform advanced heart procedures.

“Achieving this national recognition as one of the top 50 heart hospitals in America is a huge honor for the entire team at Genesis,” said Matt Perry, President and CEO of Genesis HealthCare System. “This level of exceptional care our team provides each patient is the result of many years of building an exceptional team of physicians, nurses and technicians, and implementing the latest, innovative technologies. You trusted us to care for you when you were in need of heart care, and your faith in us made this achievement possible.”

When Fortune Magazine/PINC AI, a healthcare improvement technology company, rated hospitals across the United States for 2023, Genesis ranked number seven in the community heart hospital category, the highest community ranking in Ohio.

Rankings were based on results for treating patients with a wide range of heart conditions and the cost of that care. According to Fortune Magazine/PINC AI, the winning hospitals achieved the following successes compared to non-winning hospitals:

Significantly higher inpatient survival rates (19.0 to 40.6% higher).
Fewer patients with complications (13.2 to 15.4% fewer complications).
Higher 30-day survival rates for acute myocardial infarction (AMI), heart failure (HF) and coronary artery bypass grafting (CABG) patients (0.4 to 0.9% points higher).
Lower 30-day readmission rates for AMI, HF and CABG patients (0.5 to 1.0% points lower).
Average lengths of stay varied between patient groups from 0.6 (AMI, HF, PCI) to 0.8 (CABG) shorter length of stay.
$860 to $5,076 less in total costs per patient case (the smallest dollar-amount difference was for HF, and the largest was for CABG).
Lower average 30-day episode of care payments for AMI and HF ($1,493 and $781 less per episode, respectively).
Patients had a better experience at benchmark hospitals compared to peer hospitals, with a top-box HCAHPS score of 75% versus 70%.

 “The recognition of being one of the top 50 heart hospitals is an outstanding accomplishment,” said Tabitha McKenzie, R.N., BSN, MBA, Director of Genesis Heart & Vascular Services. “The team continues to do a phenomenal job. They are dedicated to bringing the best heart care to our patients and community.”

If all hospitals performed at top 50 heart hospital levels, each year there would be more than:

7,600 lives saved.
6,700 complication-free heart patients.
$1 billion saved.

According to Fortune Magazine/PINC AI.

Genesis Heart and Vascular Care

Through every aspect of Genesis Heart & Vascular Services, we are working to build a healthier future for our community. At Genesis, we put our heart into treating yours.

Learn more

Heart Health

Mon, 04/17/2023 - 09:57

Awarded by Fortune/PINC AI

Exclude From Search

Transcarotid Artery Revascularization

Read more about Transcarotid Artery Revascularization

Watch Dr. Kunstmann Talk About the Transcarotid Artery Revascularization Procedure

Transcarotid Artery Revascularization (TCAR)

TCAR is a less-invasive method for reducing the risk of stroke and complications while treating carotid artery disease in one or both neck arteries. During the procedure, a small incision is made in the neck. A tube is inserted into the carotid artery and connected to equipment to direct blood flow away from the brain temporarily. The blood is filtered before returning to a vein in the groin. In addition to fewer risks during the TCAR procedure, a smaller incision is used to reduce scarring and procedure time is less than half compared to carotid endarterectomy. Most patients return home the day after the procedure

Genesis is one of America's Top 50 Heart Hospitals

For the 2nd year in a row, as rated by Fortune Magazine and PINC AI.

Learn more

Newsroom

Heart Health

Wed, 02/17/2021 - 08:46

Transcarotid Artery Revascularization (TCAR)

TCAR is a less-invasive method for reducing the risk of stroke and complications while treating carotid artery disease in one or both neck arteries.

Exclude From Search

MitraClip™ Implant: What You Need to Know

Read more about MitraClip™ Implant: What You Need to Know

MitraClip™ Implant Questions and Answers

1. What is mitral valve regurgitation?

a. This occurs when the mitral valve flap in your heart does not work correctly, allowing blood to leak backwards into the heart.

2. Are there symptoms?

a. You may be symptom free, or suffer from one or more of the following including a mild cough, lightheadedness, fatigue, shortness of breath that increases with activity and lying down or rapid heartbeat.

3. Is mitral valve regurgitation dangerous?

a. There are two forms of mitral valve regurgitation. Degenerative mitral regurgitation is when a valve is damaged. The damage can be from a birth defect, certain infections or aging. Degenerative mitral regurgitation can lead to strokes.

4. Who are candidates for MitraClip?

a. MitraClip can help, if you have degenerative mitral regurgitation and are considered high risk for surgery. MitraClip is a solution for functional mitral disease if treatments did not help.

5. What happens during the procedure?

a. The MitraClip implant is a one time, minimally invasive procedure. The implant is inserted through a vein in your upper leg and guided to your heart, where it is attached to your mitral valve.

General anesthesia is used so you will be asleep during the procedure.

6. How does MitraClip help?

a. After the MitraClip is attached to the malfunctioning mitral valve in your heart, it will help the valve to close properly and restore normal blood flow through the heart.

7. What happens after the procedure?

a. You will stay in the hospital for one to three days. After the implant, you will take a blood thinner and aspirin. A checkup will occur in 30 days and at one year.

8. Who is on the procedure team?

a. A trained and experienced team of physicians make up the MitraClip team. The team includes Kinan Kassar, M.D., Interventional Cardiologist, Mahmoud Farhoud, M.D., Cardiologist Imaging Specialist and Selomie Kebede, M.D., Cardiologist Imaging Specialist. Each of these physicians are part of the Genesis Heart & Vascular Group.

Genesis is one of America's Top 50 Heart Hospitals

For the 2nd year in a row, as rated by Fortune Magazine and PINC AI.

Learn more

Newsroom

Heart Health

Mon, 08/24/2020 - 19:42

MitraClip™ Implant Questions and Answers

Exclude From Search

Advanced Minimally Invasive Treatments Tackle Structural Heart Disease

Read more about Advanced Minimally Invasive Treatments Tackle Structural Heart Disease

It's been said "it always seems impossible until it's done." This statement couldn't be truer for the advanced minimally invasive treatments used today for structural heart disease. As one of the most exciting and fastest growing fields in cardiovascular medicine, technological developments over the last decade have led to previously unthinkable procedures becoming a successful option for a wide range of patients with defects or disorders in their heart's structure.

Not all heart disease is the same

Eating healthy and exercising is important for preventing coronary heart disease, which is caused by plaque buildup in the arteries that can cause chest pain and even heart attack. But, structural heart disease is different.

A heart problem that is structural may be present at birth (congenital) causing conditions such as a hole within the chambers of the heart. Structural heart disease acquired through wear and tear due to aging and time can lead to a tight aortic valve (aortic stenosis), or a leaky heart valve (mitral valve regurgitation) causing some blood to leak backward through the valve.

For patients with severe aortic stenosis, or narrowing of the aortic valve, the only treatment option for the last 50 years has been open heart surgery. While open heart surgery may still be a solution for some patients, minimally invasive catheter-based therapies have made care easier, with fewer complications and quicker recoveries.

Minimally invasive evolution: TAVR

As the most common structural heart disease treated today, heart valve disease is being successfully managed with non-surgical minimally invasive procedures, including transcatheter aortic valve replacement (TAVR). An increasingly-popular alternative to surgical repair, TAVR is a proven alternative to more traditional aortic valve surgery for both the medium or high-risk patient, and has more recently expanded as an option for those at lower risk. In fact, statistics from the Society of Thoracic Surgeons reports the number of U.S. TAVR procedures has risen from less than 5,000 in 2012 to more than 50,000 in 2018.

TAVR is a complete paradigm shift. Often completed through a tiny nick in the groin or a small cut in the neck, TAVR is performed by using a tube called a catheter and tools that fit inside the catheter. By putting the catheter into a blood vessel, we move it through the blood vessel into the heart.

The catheter holds a new artificial valve, which is then implanted or deployed into the damaged aortic valve. As the artificial valve expands it takes the place of the damaged valve. The TAVR procedure repairs the heart valve without removing the damaged valve.

After an average one or two day stay in the hospital, TAVR patients can resume normal activities within a week following the procedure. TAVR was initially approved for high-risk patients in poor health who weren't considered good candidates for traditional open-heart surgery. Now, essentially anyone who has symptomatic aortic valve stenosis is a candidate for TAVR.

Signs it's time to take steps for healing

While some people with aortic valve stenosis may not experience symptoms for many years, the disease has typically progressed to an advanced stage by the time mild to severe symptoms are noticed. A wide range of warning signs that may indicate severe narrowing of the valve and treatment is necessary, include:

Abnormal heart sound (heart murmur) heard through a stethoscope
Chest pain (angina) or tightness with activity
Feeling faint or dizzy or fainting with activity
Shortness of breath, especially when after being active
Fatigue, especially during times of increased activity
Heart palpitations (sensations of a rapid, fluttering heartbeat)

Aortic valve stenosis may also lead to heart failure, with signs and symptoms of heart failure include fatigue, shortness of breath and swollen ankles and feet.

Studies show that 50% of patients who don't receive a valve replacement are unlikely to survive more than an average of two years after symptoms begin,. While the procedure isn't without its risks, including bleeding problems and stroke, any patient who has severe aortic stenosis should be considered for TAVR.

Ready to take the next step in your journey?

Make an appointment to see how Genesis HealthCare System can help

Schedule online Call to Schedule

Beyond TAVR: MitraClip

As TAVR evolves for treatment of aortic valve narrowing, technology is addressing another form of structural heart disease: mitral regurgitation or leaky heart valve. Known as the MitraClip™, the innovative transcatheter device has been used since 2013 to provide relief of leaky heart valve without the risk of conventional surgery.

Five years later, research showed transcatheter mitral valve repair with the MitraClip significantly reduces hospitalization and all-cause mortality compared with medical therapy alone. In patients with heart failure and moderate-to-severe or severe mitral regurgitation who continue to have symptoms despite optimal medical therapy, MitraClip is a successful treatment option. In addition, the FDA's broadened approval of the device supports MitraClip as an option for a broad range of patients with mitral regurgitation.

People who have abnormalities of the mitral valve can develop heart failure symptoms such as shortness of breath, fatigue and swelling in the legs — signs the valve is leaking severely.

A minimally invasive catheter-based procedure, MitraClip treats a severely leaking mitral valve by inserting the implant through a catheter inserted in a vein in the upper leg and guided to the heart. Once the implant (a clip) is attached to the mitral valve it can then close properly to restore normal blood flow.